Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Plos One|July 12, 2013
Amyloid-β protofibrils: size, morphology and synaptotoxicity of an engineered mimicAnatoly Dubnovitsky, Anders Sandberg, M Mahafuzur Rahman, et al.BMC Biotechnology|November 1, 2008
Recombinant amyloid beta-peptide production by coexpression with an affibody ligandBertil Macao, Wolfgang Hoyer, Anders Sandberg, et al.Journal of the American Chemical Society|June 19, 2009
Protein autoproteolysis: conformational strain linked to the rate of peptide cleavage by the pH dependence of the N --> O acyl shift reactionDenny G A Johansson, Göran Wallin, Anders Sandberg, et al.Biochimica Et Biophysica Acta|May 15, 2002
Crystal structure of the double azurin mutant Cys3Ser/Ser100Pro from Pseudomonas aeruginosa at 1.8 A resolution: its folding-unfolding energy and unfolding kineticsMats Okvist, Nicklas Bonander, Anders Sandberg, et al.Alzheimer'S Research & Therapy|May 20, 2026
Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trialZsófia Lovró, Anders Sandberg, Henrik Zetterberg, et al.ACS Chemical Neuroscience|December 15, 2018
Hacking the Brain: Dimensions of Cognitive EnhancementMartin Dresler, Anders Sandberg, Christoph Bublitz, et al.Neuropharmacology|July 26, 2012
Non-pharmacological cognitive enhancementMartin Dresler, Anders Sandberg, Kathrin Ohla, et al.Alzheimer'S Research & Therapy|December 28, 2022
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extractsAnders Sandberg, Ernesto Berenjeno-Correa, Rosa Crespo Rodriguez, et al.Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineeringAnders Sandberg, Leila M Luheshi, Sofia Söllvander, et al.Pageof 4